Rare diseases
Investigational molecules
Locations
Back to Germany1 819 clinical trials in Potsdam, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of SAR442970 to treat moderate to severe ulcerative colitis in adults
GermanyStudy comparing venglustat tablets with standard therapy for adult patients with Fabry disease and left ventricular hypertrophy
GermanyLong-term study of dabrafenib and trametinib in children and adolescents with cancers that have V600 mutation
GermanyStudy of VRDN-001 compared to placebo to evaluate safety and effectiveness in adults with chronic thyroid eye disease
GermanyStudy of datopotamab deruxtecan with or without durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
GermanyStudy of tozorakimab to reduce exacerbations in former smokers with chronic obstructive pulmonary disease (COPD)
GermanyStudy of bitopertin to improve sunlight tolerance in adults with erythropoietic protoporphyria or X-linked protoporphyria
GermanyStudy of BLU-808 tablets compared to placebo in adults with chronic inducible urticaria and chronic spontaneous urticaria
GermanyComparing weekly insulin icodec and daily insulin glargine with insulin aspart in adults with type 1 diabetes: a 26-week study of blood sugar control
GermanyLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
GermanyStudy of inhaled BX004 bacteriophage treatment for adults with cystic fibrosis who have chronic Pseudomonas aeruginosa lung infection
GermanyStudy of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on breast cancer treatments, including studies for triple-negative, HER2-positive, and hormone receptor-positive variants. Research encompasses new combination therapies and targeted treatments.
Multiple studies are evaluating novel drug combinations and personalized therapeutic approaches.
Clinical research targeting various skin conditions, including atopic dermatitis and chronic skin disorders. Studies focus on both topical and systemic treatments.
Investigations include both traditional and innovative therapeutic approaches for skin conditions.
Studies focusing on multiple sclerosis treatment options, evaluating new medications and comparing their effectiveness to existing therapies.
Research aims to improve treatment outcomes and quality of life for patients with neurological conditions.
Research focusing on cardiovascular disease management and innovative treatments for related conditions, including studies on lipid management.
Trials aim to reduce major cardiovascular events and improve patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
